Company Name | Grifols |
---|---|
Website | https://www.grifols.com |
Snippet | Grifols is a leading global healthcare company that develops medicines derived from plasma and other innovative biotech solutions to enable millions of patients around the world to lead more rewarding lives. |
ISIN | ES0171996012 |
Type | Sociedad Anónima |
Founded | 1940 |
Revenue | €3.934 billion (2015), €3.355 billion (2014) [1]: 8 |
Website | www.grifols.com |
Industry | Pharmaceuticals, chemicals |
Products | Plasma derivatives, in vitro diagnostic products, non-biological products for laboratories and hospitals |
Traded as | BMAD: GRF, Nasdaq: GRFS |
Key people | Víctor Grífols (Chairman and CEO) |
Net income | €532.1 million (2015), €470.3 million (2014)[1]: 8 |
Headquarters | Barcelona, Spain |
Total assets | €9.601 billion (2015), €8,449.7 million (2014)[1]: 6 |
Total equity | €3.3014 billion (2015), €2,662.9 million (2014)[1]: 7 |
Operating income | €970.4 million (2015), €857.7 million (2014) [1]: 8 |
Number of employees | 21,500 (2019, average) [1]: 64 |
Grifols is part of the Spain company list
Grifols is part of the Chemicals company list
Grifols is part of the Pharmaceuticals company list
Have a list of company names and need to update information? Use our Company Search tool.
Please note that Powrbot Inc does not own this content and cannot vouch for its accuracy, we simply aggregate public information for ease of research.
Want to update this profile? Please contact us here with a link to the public source verifying the edit.
Powrbot Inc. is a passionate company working on problems using data analytics, automation & machine learning. Our goal is to automate the boring stuff.
Contact Us